Cargando…
Synergistic drug combinations improve therapeutic selectivity
Prevailing drug discovery approaches focus on compounds with molecular selectivity, inhibiting disease-relevant targets over others in vitro. However in vivo, many such agents are not therapeutically selective, either because of undesirable activity at effective doses or because the biological syste...
Autores principales: | Lehàr, Joseph, Krueger, Andrew S., Avery, William, Heilbut, Adrian M., Johansen, Lisa M., Price, E. Roydon, Rickles, Richard J., Short, Glenn F., Staunton, Jane E., Jin, Xiaowei, Lee, Margaret S., Zimmermann, Grant R., Borisy, Alexis A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708317/ https://www.ncbi.nlm.nih.gov/pubmed/19581876 http://dx.doi.org/10.1038/nbt.1549 |
Ejemplares similares
-
High-order combination effects and biological robustness
por: Lehár, Joseph, et al.
Publicado: (2008) -
Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug
por: Zimmermann, Grant R, et al.
Publicado: (2009) -
Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication
por: Owens, Christopher M, et al.
Publicado: (2010) -
Barochmusik vierhändig
por: Heilbut, Peter
Publicado: (1989) -
Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis
por: Kvien, T K, et al.
Publicado: (2008)